11/8
07:00 am
bpth
Bio-Path Holdings to Announce Third Quarter 2024 Financial Results on November 15, 2024
Low
Report
Bio-Path Holdings to Announce Third Quarter 2024 Financial Results on November 15, 2024
10/31
02:04 am
bpth
Bio-Path Holdings, Inc. (NASDAQ: BPTH) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Bio-Path Holdings, Inc. (NASDAQ: BPTH) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
10/23
02:06 am
bpth
Bio-Path Holdings, Inc. (NASDAQ: BPTH) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Bio-Path Holdings, Inc. (NASDAQ: BPTH) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
10/17
04:49 pm
bpth
Bio-Path files to sell 17.76M shares of common stock for holders [Seeking Alpha]
Medium
Report
Bio-Path files to sell 17.76M shares of common stock for holders [Seeking Alpha]
10/15
02:07 am
bpth
Bio-Path Holdings, Inc. (NASDAQ: BPTH) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Bio-Path Holdings, Inc. (NASDAQ: BPTH) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
10/10
05:24 pm
bpth
Bio-Path Holdings Announces Closing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Low
Report
Bio-Path Holdings Announces Closing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
10/9
09:53 am
bpth
Bio-Path announces $4M private placement [Seeking Alpha]
Medium
Report
Bio-Path announces $4M private placement [Seeking Alpha]
10/8
08:00 pm
bpth
Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Medium
Report
Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
10/8
09:33 am
bpth
Nano-Cap Bio-Path Takes Plunge In Weight Loss Race, Initiates Obesity Program With Drug Candidate Under Development For Blood Cancer [Yahoo! Finance]
Medium
Report
Nano-Cap Bio-Path Takes Plunge In Weight Loss Race, Initiates Obesity Program With Drug Candidate Under Development For Blood Cancer [Yahoo! Finance]
10/8
07:00 am
bpth
Bio-Path Holdings Initiates Development of Therapeutic Program for Treatment of Obesity
High
Report
Bio-Path Holdings Initiates Development of Therapeutic Program for Treatment of Obesity
10/7
02:05 am
bpth
Bio-Path Holdings, Inc. (NASDAQ: BPTH) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Bio-Path Holdings, Inc. (NASDAQ: BPTH) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
9/29
02:13 am
bpth
Bio-Path Holdings, Inc. (NASDAQ: BPTH) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Bio-Path Holdings, Inc. (NASDAQ: BPTH) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
9/21
02:32 am
bpth
Bio-Path Holdings, Inc. (NASDAQ: BPTH) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Bio-Path Holdings, Inc. (NASDAQ: BPTH) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
9/16
07:00 am
bpth
Bio-Path Holdings Announces Publication in Biomedicines
High
Report
Bio-Path Holdings Announces Publication in Biomedicines
9/3
07:00 am
bpth
Bio-Path Holdings to Present at H.C. Wainwright 26th Annual Global Investment Conference
High
Report
Bio-Path Holdings to Present at H.C. Wainwright 26th Annual Global Investment Conference
8/21
07:00 am
bpth
Bio-Path Holdings Reports Solid Tumor Patient Response Supporting BP1001-A’s Compelling Potential as Treatment for Advanced Solid Tumors
Low
Report
Bio-Path Holdings Reports Solid Tumor Patient Response Supporting BP1001-A’s Compelling Potential as Treatment for Advanced Solid Tumors
8/15
07:00 am
bpth
Bio-Path Holdings Reports Second Quarter 2024 Financial Results
Medium
Report
Bio-Path Holdings Reports Second Quarter 2024 Financial Results